On February 7, 2024, Universal Ibogaine Inc. closed the transaction. The company issued 29,219,250 common shares at an issue price of CAD 0.01 per share for gross proceeds CAD 292,192.5., resulting in an aggregate issuance of 41,719,250 common shares for gross proceeds of CAD 417,192. Completion of the Placement remains subject to the final approval of the TSX Venture Exchange (?TSXV?). All securities issued in connection with the Offering will be subject to a four-month hold period as required by the rules of the TSXV and Canadian Securities Laws, as well as any required hold periods under US Securities Laws for US resident purchasers.

The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement. The transaction included participation from 6 placees.